These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35311121)

  • 21. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
    Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
    Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
    [No Abstract]   [Full Text] [Related]  

  • 22. LIMK1: A promising prognostic and immune infiltration indicator in colorectal cancer.
    Liu X; Song Q; Wang D; Liu Y; Zhang Z; Fu W
    Oncol Lett; 2022 Jul; 24(1):234. PubMed ID: 35720504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates.
    Fang Y; Liu J; Zhang Q; She C; Zheng R; Zhang R; Chen Z; Chen C; Wu J
    World J Surg Oncol; 2022 Jun; 20(1):211. PubMed ID: 35729567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of HMGB3 and its prognostic value in breast cancer.
    Zhou X; Zhang Q; Liang G; Liang X; Luo B
    Front Oncol; 2022; 12():1048921. PubMed ID: 36620553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FN1 overexpression is correlated with unfavorable prognosis and immune infiltrates in breast cancer.
    Zhang XX; Luo JH; Wu LQ
    Front Genet; 2022; 13():913659. PubMed ID: 36035176
    [No Abstract]   [Full Text] [Related]  

  • 26. Comprehensive analysis of EML2 as a prognostic biomarker in colon cancer.
    Sun Y; Han L; Sun D
    Int J Clin Exp Pathol; 2024; 17(1):1-12. PubMed ID: 38322176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of SPOCK2 expression signature for high-grade serous ovarian cancer patients.
    Jiao M; Sun W; Li L; Li C; Zhou J; Li Q; Duan L
    Front Genet; 2022; 13():878123. PubMed ID: 36246613
    [No Abstract]   [Full Text] [Related]  

  • 28. Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer.
    Fang Z; Song YX; Wo GQ; Zhou HL; Li L; Yang SY; Chen X; Zhang J; Tang JH
    Ann Transl Med; 2022 Dec; 10(23):1280. PubMed ID: 36618780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PCMT1 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltrates in Breast Cancer.
    Guo J; Du X; Li C
    Biomed Res Int; 2022; 2022():4434887. PubMed ID: 35535040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel immune-related prognostic index for predicting breast cancer overall survival.
    Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
    Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ANXA9 as a novel prognostic biomarker associated with immune infiltrates in gastric cancer.
    Zhang T; Yu S; Zhao S
    PeerJ; 2021; 9():e12605. PubMed ID: 35003923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.
    Li X; Gao Y; Xu Z; Zhang Z; Zheng Y; Qi F
    Cancer Med; 2020 Feb; 9(3):1161-1172. PubMed ID: 31856409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioinformatic Analysis of Prognostic Value of SNTG2 with Immune Implications in Lung Adenocarcinoma.
    Zhou J; Wen Y; Chen X; Guo L
    Int J Gen Med; 2022; 15():5181-5196. PubMed ID: 35637702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast Cancer.
    Li F; Zhang Y; Shi Y; Liu S
    Crit Rev Eukaryot Gene Expr; 2021; 31(4):71-79. PubMed ID: 34587437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive Analysis of the Immune and Prognostic Implication of TRIM8 in Breast Cancer.
    Yan C; Liu Q; Nie M; Hu W; Jia R
    Front Genet; 2022; 13():835540. PubMed ID: 35368651
    [No Abstract]   [Full Text] [Related]  

  • 36. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
    Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
    Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioinformatics and Experimental Analysis of the Prognostic and Predictive Value of the CHPF Gene on Breast Cancer.
    Li WW; Liu B; Dong SQ; He SQ; Liu YY; Wei SY; Mou JY; Zhang JX; Liu Z
    Front Oncol; 2022; 12():856712. PubMed ID: 35372047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased Neuromedin B is Associated with a Favorable Prognosis in Glioblastoma.
    Li S; Li S; Li Q; Liu F; Liao W; Yu L; Ouyang C; Xia H; Liu C; Li M
    Front Biosci (Landmark Ed); 2023 Mar; 28(3):54. PubMed ID: 37005748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic and prognostic role of basic leucine zipper transcription factor in kidney renal clear cell carcinoma.
    Zhang H; Zhang H; Hu Y; Huang B; Chen J; Chen L
    Transl Androl Urol; 2022 Feb; 11(2):238-252. PubMed ID: 35280662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCDC134 is down-regulated in gastric cancer and its silencing promotes cell migration and invasion of GES-1 and AGS cells via the MAPK pathway.
    Zhong J; Zhao M; Luo Q; Ma Y; Liu J; Wang J; Yang M; Yuan X; Sang J; Huang C
    Mol Cell Biochem; 2013 Jan; 372(1-2):1-8. PubMed ID: 23070808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.